Calcium–phosphate metabolism in patients with multiple sclerosis

Calcium–phosphate metabolism in patients with multiple sclerosis

Bibliographic Details
Main Authors:	Kubicka-Baczyk, K., Labuz-Roszak, B., Pierzchala, K., Adamczyk-Sowa, M., Machowska-Majchrzak, A.
Format:	Online
Language:	English
Published:	Springer International Publishing 2015
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4429145/

Similar Items

Oral anticoagulant and antiplatelet drugs used in prevention of cardiovascular events in elderly people in Poland
by: Labuz-Roszak, Beata, et al.
Published: (2012)

Searching for factors associated with resistance to acetylsalicylic acid used for secondary prevention of stroke
by: Łabuz-Roszak, Beata, et al.
Published: (2015)

Assessment of Biochemical and Densitometric Markers of Calcium-Phosphate Metabolism in the Groups of Patients with Multiple Sclerosis Selected due to the Serum Level of Vitamin D3
by: Natalia Niedziela, et al.
Published: (2018-01-01)

Resistance to acetylsalicylic acid in patients with type 2 diabetes mellitus is associated with lipid disorders and history of current smoking
by: Łabuz-Roszak, B., et al.
Published: (2014)

Changes in Serum Ceruloplasmin Levels Based on Immunomodulatory Treatments and Melatonin Supplementation in Multiple Sclerosis Patients
by: Adamczyk-Sowa, Monika, et al.
Published: (2016)

New Insights into the Role of Oxidative Stress Mechanisms in the Pathophysiology and Treatment of Multiple Sclerosis
by: Adamczyk, Bożena, et al.
Published: (2016)

Melatonin Acts as Antioxidant and Improves Sleep in MS Patients
by: Adamczyk-Sowa, Monika, et al.
Published: (2014)

Ethnic differences in calcium, phosphate and bone metabolism
by: Redmond, J., et al.
Published: (2014)

Clinical management of disturbances of calcium and phosphate metabolism in dialysis patients
by: Eddington, Helen, et al.
Published: (2009)

Serum Metabolic Profile in Multiple Sclerosis Patients
by: Tavazzi, Barbara, et al.
Published: (2011)

Is Metabolic Flexibility Altered in Multiple Sclerosis Patients?
by: Mähler, Anja, et al.
Published: (2012)

Inositol Phosphates and Calcium Signalling
by: Whetton, A.D.
Published: (1993)

Gender and Uveitis in Patients with Multiple Sclerosis
by: Gordon, Lynn K., et al.
Published: (2014)

Application of Calcium Phosphate Materials in Dentistry
by: Al-Sanabani, Jabr S., et al.
Published: (2013)

The cost of multiple sclerosis in Norway
by: Svendsen, B., et al.
Published: (2010)

Preparation and properties of porous calcium phosphate
by: Jawatankuasa Kerja PSM UniMAP
Published: (2008)

Physico-chemical properties of calcium phosphates
by: Babić-Ivančić Vesna, et al.
Published: (2012-01-01)

Dielectric Properties of Calcium Phosphate Ceramics
by: Omer KAYGILI, et al.
Published: (2016-05-01)

Calcium-modified zinc phosphate pretreatment
Published: (1998)

Perturbed Glucose Metabolism: Insights into Multiple Sclerosis Pathogenesis
by: Mathur, Deepali, et al.
Published: (2014)

Metabolic Reprograming of Mononuclear Phagocytes in Progressive Multiple Sclerosis
by: Tannahill, Gillian Margaret, et al.
Published: (2015)

A Review Paper on Biomimetic Calcium Phosphate Coatings
by: Lin, X., et al.
Published: (2015)

Effect of calcium phosphate and vitamin D3 supplementation on bone remodelling and metabolism of calcium, phosphorus, magnesium and iron
by: Trautvetter, Ulrike, et al.
Published: (2014)

Comorbidity and metabolic syndrome in patients with multiple sclerosis from Asturias and Catalonia, Spain
by: Antoni Sicras-Mainar, et al.
Published: (2017-07-01)

Metabolic response to glatiramer acetate therapy in multiple sclerosis patients
by: De Riccardis, Lidia, et al.
Published: (2016)

Calcium phosphates and silicon: exploring methods of incorporation
by: Ana I. Rodrigues, et al.
Published: (2017-04-01)

Effects of bismuth oxide on the properties of calcium phosphate bioceramics
by: W., H. Yeo, et al.
Published: (2011)

Treatment of multiple sclerosis
by: Pandit, Lekha, et al.
Published: (2011)

Lymphocytes subset composition and modulation of sphingosie-1-phosphate mediated migration in multiple sclerosis patients treated with fingolimod or interferon-β
by: Sic, Heiko, et al.
Published: (2012)

Autoimmune markers in patients with multiple sclerosis
by: Lim, T.T., et al.
Published: (2010)

Comparative evaluation of biphasic calcium phosphate and biphasic calcium phosphate collagen composite on osteoconductive potency in rabbit calvarial defect
by: Lee, Eun-Ung, et al.
Published: (2015)

Introduction to the Special Issue: Dental Chemistry of Calcium Phosphates
by: Carey, Clifton M.
Published: (2010)

Improving communication with multiple sclerosis patients
by: Alroughani, Raed A.
Published: (2015)

Invasive fungal infection of the central nervous system in a patient with acute myeloid leukaemia
by: Janik-Moszant, Anna, et al.
Published: (2012)

STUDIES ON CALCIUM AND MAGNESIUM METABOLISM IN DISEASE : II. CALCIUM AND MAGNESIUM METABOLISM IN MULTIPLE CARTILAGINOUS EXOSTOSIS.
by: Underhill, Frank P., et al.
Published: (1920)

Synthesis and characterization of magnesium doped biphasic calcium phosphate
by: A R, Toibah, et al.
Published: (2008)

Inositol phosphate formation and its relationship to calcium signaling.
by: Hughes, A R, et al.
Published: (1990)

Repetitive element hypermethylation in multiple sclerosis patients
by: Neven, K. Y., et al.
Published: (2016)

Effects of paricalcitol on calcium and phosphate metabolism and markers of bone health in patients with diabetic nephropathy: results of the VITAL study
by: Coyne, Daniel W., et al.
Published: (2013)

MULTIPLE SCLEROSIS
by: Ivan M., Sharman
Published: (1987)